Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Paweletz CP, Heavey GA, Kuang Y, Durlacher E, et al. Early changes in circulating cell free KRAS G12C predicts response to adagrasib in KRAS mutant non-small cell lung cancer patients. Clin Cancer Res 2023 Jun 6:CCR-23-0795. doi: 10.1158/1078-0432.CCR-23-0795.
PMID: 37279096


Privacy Policy